Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.125 USD | +0.36% | +4.33% | +10.91% |
09/05 | NeuroBo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/05 | Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target | MT |